Evaluation of clinical effect of ghrelin on QOL of patients with lung cancer

Evaluation of clinical effect of ghrelin on QOL of patients with lung cancer - Evaluation of clinical effect of ghrelin on QOL of patients with lung cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007970

Enrollment

Registered

2012-05-17

Start date

2012-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced lung cancer

Interventions

ghrelin saline

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The eligibility criteria for the study were as follows: 1) histopathologically confirmed squamous cell carcinoma, or adenocarcinoma, or small cell carcinoma of the lung; 2) non-resectable lung cancer; 3) ages 20 to 80 years; 4) adequate function of major organs; 5) no other active malignancy; 6) an Eastern Cooperative Oncology Group performance status (PS) of 0 or 1; and, 7) provision of written informed consent.

Exclusion criteria

Exclusion criteria: The exclusion criteria for the study were as follows: 1) pregnant or potentially (willingly) pregnant women; 2) a past history of other chemotherapy or radiotherapy; and, 3) patients judged to be ineligible by the investigator.

Design outcomes

Primary

Measure	Time frame
dietary intake	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026